INTERSECT is based in Seattle at the University of Washington. For a complete list of team members, click here.
Eoin West, MD, MPH Director
Dr. West's academic interests center on respiratory diseases and critical illness in low resource settings. His primary research focus is innate immunity in lung infections and sepsis. In association with colleagues from Mahidol University, Bangkok, University of Oxford, and the London School of Hygiene and Tropical Medicine, and clinicians at hospitals in northeast Thailand, he studies host defense in melioidosis, a lethal tropical infection, as well as invasive Staphylococcus aureus infection.
A second research focus is the epidemiology and clinical management of lung infections and sepsis in low resource settings. He partners with colleagues from University of Health Sciences and Kampong Cham Provincial Hospital, Cambodia to study the epidemiology and management of melioidosis in Cambodia.
He is also involved in educational initiatives promoting optimal care of critically ill patients in low resources setting. In the past, he has contributed to development and testing of clinical sepsis management guidelines in low resource settings in collaboration with members of the Integrated Management of Adolescent and Adult Illness team and Global Alert and Response group at WHO. He presently oversees an educational partnership between the UW Division of Pulmonary & Critical Care Medicine and the University of Health Sciences, Cambodia. He is actively involved in the UW Medical Center’s International Nursing Program.
Amelie von Saint André-von Arnim, MD Associate Director
Dr. von Saint André – von Arnim’s academic focus is on improving care of critically-ill children in resource limited settings. In collaboration with faculty at the University of Washington, she is helping the University of Nairobi develop a pediatric acute care training program in Kenya for pediatricians from sub-Saharan Africa. She is involved in research projects to evaluate prevalence and outcomes of pediatric critical illness in low and low-middle income countries.
Shevin Jacob, MD, MPH Associate Director
Since 2006, Dr. Jacob has spent the majority of his time working as a researcher, instructor, and clinician in Uganda. His primary research focus is on the management and pathogenesis of patients hospitalized with sepsis syndromes, primarily at two Ugandan government hospitals--Mulago National Referral Hospital and Masaka Regional Referral Hospital. He is actively involved in the Makerere University Walter Reed Project, a non-profit partnership between Makerere University and the U.S. Military HIV Research Program.
In addition, he has been a consultant for WHO working and writing groups, which focus on improving the management of critically ill patients in austere settings.
Lia Golden, CCRN, BSN, RN Assistant Director for Nursing
Mrs. Golden is a critical care nurse at the University of Washington Medical Center and has worked the past 8 years with critically ill medical, surgical, and transplant patients. She is committed to improving health through nursing education and training and is a leader in the field of international nursing. Mrs. Golden has worked throughout Brazil and in Phnom Penh Cambodia hosting classes, conducting bedside didactics, and being a featured lecturer for international nursing symposiums. In 2011 Mrs. Golden spent 4 months volunteering abroad helping a team of providers start the first transplant centers in the rural Amazon regions of Brazil. This work led her to create the International Nursing Program (INP) and in 2014 Mrs. Golden created the INP at the University of Washington Medical Center (UWMC) in order to strengthen global nursing education through partnering UWMC nurses with nurses from low to middle income countries around the world. Mrs. Golden is earning her doctorate in nursing degree (DNP) from the University of Washington.
Justin Ortiz, MD, MS Former Associate Director
Justin is a scientist in the Initiative for Vaccine Research at the World Health Organization in Geneva Switzerland. In this position, he is the technical lead for influenza vaccines, coordinating organization activities that inform and support sustainable seasonal influenza vaccination in low and middle income countries and promoting the development of novel influenza vaccine technologies for seasonal and pandemic influenza.